Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 26
  • 0 comments

FDA approve TRIAZOLAM

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Comment Full text

HIKMA INTL PHARMS

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 31
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

OXFORD PHARMS

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 27
  • 0 comments

FDA approve SPIRONOLACTONE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 28
  • 0 comments

FDA approve HALOPERIDOL LACTATE

Comment Full text

ACIC PHARMS

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 26
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text

NOVARTIS

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 30
  • 0 comments

FDA approve BRINZOLAMIDE

Comment Full text

INTRA-CELLULAR

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 27
  • 0 comments

FDA approve LUMATEPERONE TOSYLATE

Comment Full text

VIVUS

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 28
  • 0 comments

FDA approve PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

Comment Full text

TORRENT

  • FDA Approval
  • June 29, 2023, 11:41 UTC
  • 27
  • 0 comments

FDA approve AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Comment Full text
  • Previous
  • 768
  • 769
  • 770
  • 771
  • 772
  • Next

Search

News categories

  • Technical Exchange News(12075)
  • Event(5338)
  • SEC News(251031)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150384)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin